HIV and (Re)Emerging Viruses: Aligning Lessons Across Pandemics (K1)
April 8-11, 2024
| Herrenhausen Palace, Hannover, Germany
Melanie M. Ott, Priti Kumar, Olivier Schwartz and Alex Sigal
Scholarship Deadline: Jan. 17, 2024 | Abstract Deadline: Jan. 17, 2024 | Early Registration Deadline: Feb. 7, 2024
| 4:00–8:00 PM |
Registration |
Grand Mussmann Hotel, Tivoli Room |
| 6:00–8:00 PM |
Welcome Mixer |
Central-Hotel Kaiserhof |
| 8:00–9:00 AM |
Breakfast |
Individual Hotel |
| 8:30–9:00 AM |
Poster Setup |
Foyer |
| 9:00–10:00 AM |
Welcome and Keynote Address |
Auditorium |
| |
Sarah Catherine Gilbert, University of Oxford
Preparing to Vaccinate Against the Next Pandemic |
|
| 9:00–7:00 PM |
Poster Viewing |
Foyer |
| 10:00–12:15 PM |
Pathogenesis I- Viral Emergence |
Auditorium |
| |
Stefan Pöhlmann, Deutsches Primatenzentrum GmbH
Principles of Coronaviral Infections |
|
| |
Geoffrey L. Smith, University of Oxford
Host-Virus Interactions with Monkeypox Virus |
|
| |
Jérémy Dufloo, Universitat de València
Short Talk: Short Talk: Viral Entry is a Weak Barrier to Zoonosis |
|
| |
Paige Fletcher, NIAID, NIH
Short Talk: Short Talk: Taï Forest Virus: The Virus Sequence Determines the Pathogenic Potential |
|
| |
Max Josef J Kellner, IMBA
Short Talk: Short Talk: Bat Organoids: Understanding Emerging Virus Infections through the Lens of Reservoir Species |
|
| 10:30–10:50 AM |
Coffee Break |
Foyer |
| 12:15–1:15 PM |
Lunch |
Ballroom |
| 1:00–3:00 PM |
Poster Session 1 |
Foyer |
| 3:30–4:30 PM |
Career Roundtable |
Auditorium |
| |
Penny L. Moore, University of the Witwatersrand and National Institute for Communicable Diseases
Research Chair & Professor |
|
| |
Joel N. Blankson, Johns Hopkins School of Medicine
Professor of Medicine |
|
| |
Irini Sereti, NIAID, National Institutes of Health
Senior Investigator |
|
| |
Valentin Le Douce, BioNTech SE
Associate Director - Infectious Disease Vaccines |
|
| 4:30–5:00 PM |
Coffee Available |
Foyer |
| 5:00–7:00 PM |
Pathogenesis II- Molecular Mechanisms |
Auditorium |
| |
Melanie M. Ott, Gladstone Institute of Virology
How Viral Proteins Shape HIV and SARS-CoV-2 Pathogenesis |
|
| |
Wendy Barclay, Imperial College London
Lessons Learned from Flu and SARS-CoV-2 |
|
| |
Kei Sato, The University of Tokyo
Pathogenicity of Omicron Subvariants |
|
| |
Sharon R. Lewin, University of Melbourne
mRNA Therapeutics for SARS-CoV2 and HIV latency |
|
| |
Lisa Lasswitz, University of Veterinary Medicine Hannover
Short Talk: Short Talk: CD81 is a Host Factor for Chikungunya Virus Replication |
|
| 7:00–8:00 PM |
Social Hour with Lite Bites |
Ballroom |
Wednesday, April 10, 2024
| 8:00–9:00 AM |
Breakfast |
Individual Hotel |
| 8:30–9:00 AM |
Poster Setup |
Foyer |
| 9:00–12:00 PM |
Common Lessons in Prevention |
Auditorium |
| |
Penny L. Moore, University of the Witwatersrand and National Institute for Communicable Diseases
Antibody Responses in People Living with HIV |
|
| |
Olivier Schwartz, Institut Pasteur
Entry and Replication of Human Seasonal Coronaviruses and Recent SARS-CoV-2 Variants |
|
| |
Joel N. Blankson, Johns Hopkins School of Medicine
Natural Immunity to HIV |
|
| |
Daniel Lingwood, Harvard Medical School
Short Talk: Short Talk: Eliciting a Single Amino Acid Change by Vaccination Enables Cross-Group Protective Influenza Antibodies |
|
| |
Matthew Sutton, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Short Talk: Short Talk: Evaluating Mechanisms of Protection by Broadly Reactive Anti-Alphavirus Antibodies |
|
| 9:00–7:00 PM |
Poster Viewing |
Foyer |
| 10:00–10:20 AM |
Coffee Break |
Foyer |
| 12:00–1:00 PM |
Lunch |
Ballroom |
| 12:30–2:30 PM |
Poster Session 2 |
Foyer |
| 2:30–4:30 PM |
Workshop 1 |
Auditorium |
| |
Ulrike Lange, Heinrich Pette Institute
Transcriptional Activity of Proviral Sequences as Driver for Clonal Expansion in Chronic HIV Infection |
|
| |
Dania Figueroa Acosta, Icahn School of Medicine at Mount Sinai
Endocytic Recycling-Dependent Env Antigenic States Affect Neutralization of Cell-Free and Cell-Cell Infection by Broadly Neutralizing Antibodies |
|
| |
Uwem Etop George, African Centre of Excellence for Genomics of Infectious Diseases
Whole Genome Sequencing Reveals Cryptic Circulation of Dengue Virus in the Rainforest Region of Nigeria, West Africa |
|
| |
Shlomi Ilan, Ragon Institute of MGH, MIT and Harvard
Functional Antibody Signatures Following Combined Active and Passive Therapeutic Immunization of SHIV-infected Rhesus Macaques |
|
| |
Nell Saunders, Institut Pasteur
TMPRSS2 is a Functional Receptor for Human Coronavirus HKU1 |
|
| |
Taha Y. Taha, Gladstone Institutes/UCSF
Spike-Independent Evolution of Recent SARS-CoV-2 Omicron Subvariants Enhances Viral RNA Replication via NSP6 Mutations |
|
| |
Florian Kabinger, Max Planck Institute for Multidisciplinary Sciences
Uncovering the Mechanism of Small Molecule Inhibitors Against the RNA Polymerase of SARS-CoV-2 |
|
| 4:30–5:00 PM |
Coffee Available |
Foyer |
| 5:00–7:00 PM |
Drivers of Viral Evolution |
Auditorium |
| |
Alex Sigal, Africa Health Research Institute
SARS-CoV-2 Evolution and Pathogenesis in PLWH |
|
| |
Ravindra K. Gupta, University of Cambridge
SARS-CoV-2 Spike Evolution – Balancing Infectivity with Immune Evasion |
|
| |
Emma Hodcroft, University of Basel
Evolution of HIV and Other Viruses |
|
| |
Ann-Kathrin Reuschl, University College London
Short Talk: Short Talk: SARS-CoV-2 Evolution of Innate Immune Antagonism |
|
| 7:00–8:00 PM |
Social Hour with Lite Bites |
Ballroom |
| 8:00–9:00 AM |
Breakfast |
Individual Hotel |
| 9:00–12:00 PM |
Pushing the Boundaries on Viral Therapeutics |
Auditorium |
| |
Priti Kumar, Yale School of Medicine
HIV Gene Therapy: A Time to Prevent, a Time to Control, and Now, the Time to Cure |
|
| |
Galit Alter, Moderna, Inc.
Antibodies Therapeutics in HIV, SARS, Flu, and RSV |
|
| |
Michael Z. Lin, Stanford University School of Medicine
Short Talk: Short Talk: Design of Oral Antiviral Drugs for Broad-Spectrum Activity Against Coronaviruses |
|
| |
Vijayakumar Velu, Emory University
Short Talk: Short Talk: IL-15/IL-15Ra Cytokine Therapy Leads to Control of Viral Rebound in SIV Infected Macaques |
|
| |
Tomas Raul Wiche Salinas, Emory University
Short Talk: Short Talk: Persistent Reduction of SIV Reservoir Through Short-Term BCL-2 Inhibition at ART Initiation in Rhesus Macaques |
|
| 10:00–10:20 AM |
Coffee Break |
Foyer |
| 12:00–1:00 PM |
Lunch |
Ballroom |
| 1:00–2:30 PM |
Hands-On Computer Workshop on Los Alamos HIV Sequence and Immunology Databases and Tools (HIV.lanl.gov) |
Auditorium |
| |
Brian T. Foley, Los Alamos National Lab
Los Alamos National Lab |
|
| |
Jennifer Mamrosh, Los Alamos National Laboratory
Los Alamos National Lab |
|
| 2:30–4:30 PM |
Workshop 2 |
Auditorium |
| |
Maria C Hesselman, University of Zurich
Distinct V2 Apex Broadly Neutralizing Antibody Modalities in Subtype B HIV-1 Infection |
|
| |
Doan C. Nguyen, Emory University
The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination |
|
| |
Sharidan Brown, Scripps Research
Anti-Immune Complex Antibodies are Elicited During Repeated Immunization with HIV Env Immunogens |
|
| |
Enrico Bravo, King's College London
IFNα2 Autoantibodies Post SARS-CoV-2 Wave 1 in India Are Associated with Lower Omicron Symptomology |
|
| |
Julia Hitschfel, Ragon Institute of MGH, MIT and Harvard
Transcriptional Profiling of HIV-Specific CD8 T Cell Responses From Lymph Nodes and Blood of Natural Controllers |
|
| |
Nicholas Provine, University of Oxford
Immune Signatures Associated with Failure to Seroconvert in Individuals Immunized with MVA-BN as a Vaccine Against MPOX |
|
| |
Wilfredo Garcia-Beltran, Ragon Institute of Mass General, MIT and Harvard
Evasion of NKG2D-Mediated Cytotoxic Immunity by Sarbecoviruses |
|
| |
Adam Zuiani, BioNTech US
A Multivalent mRNA Monkeypox Virus Vaccine (BNT166) Protects Mice and Macaques From Orthopoxvirus Disease |
|
| 4:30–5:00 PM |
Coffee Available |
Foyer |
| 5:00–6:45 PM |
Plenary PM |
Auditorium |
| 6:45–7:00 PM |
Post-Acute Sequelae of Viral Infections |
Auditorium |
| |
Nadia R. Roan, University of California, San Francisco
Post-Acute Sequelae of COVID-19 |
|
| |
Gabriella Worwa, NIH/NIAID/IRF-Frederick
Modeling Post-Acute Sequelae of Ebola Virus Disease |
|
| |
Irini Sereti, NIAID, National Institutes of Health
HIV and Chronic Immune Activation: The Impact of Low Nadir CD4 Counts |
|
| |
Till Omansen, Bernhard-Nocht-Institut für Tropenmedizin
Short Talk: Short Talk: Lassa Fever is Hallmarked by Inflammation and Kidney Injury or Neurological Disease: Results from the Lassa Fever PATHOGENESIS Study |
|
| 7:00–8:00 PM |
Social Hour with Lite Bites |
Ballroom |
